JAMIE BURKE: Open Payments
NPI 1417294216 · COVINGTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$838 in 42 payments from 18 companies in 2025. Trend: 2023 $678 · 2024 $785 · 2025 $838
Food & beverage: $838
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $117 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $105 |
| Lilly USA, LLC | 6 | $103 |
| AstraZeneca Pharmaceuticals LP | 4 | $68 |
| Phathom Pharmaceuticals, Inc. | 1 | $62 |
| PFIZER INC. | 3 | $61 |
| SANOFI-AVENTIS U.S. LLC | 2 | $40 |
| Boston Scientific Corporation | 1 | $38 |
| Abbott Laboratories | 2 | $33 |
| GlaxoSmithKline, LLC. | 2 | $33 |
Products named: JARDIANCE, MOUNJARO, VOQUEZNA, ELIQUIS, Ozempic, TZIELD, Wegovy, General - Pain Management.
Industry payments across GA — which companies pay providers there.
